Fresenius | FRE - Cash And Equivalent

Stock Price
49.23
Daily Change
0.24 0.49%
Monthly
3.23%
Yearly
32.55%
Q1 Forecast
45.82

Fresenius reported EUR1.23B in Cash and Equivalent for its fiscal quarter ending in June of 2025.





Cash And Equivalent Change Date
Akzo Nobel EUR 1.55B 47M Jun/2025
Alcon AG USD 1.5B 90M Sep/2025
AstraZeneca USD 8.14B 1.08B Sep/2025
BASF EUR 1.86B 658M Sep/2025
Bayer EUR 5.9B 1.34B Sep/2025
Beiersdorf EUR 1.17B 40M Jun/2025
DaVita Healthcare Partners USD 705.96M 2.46M Sep/2025
Demant DKK 1.14B 30M Jun/2025
E.ON EUR 3.1B 768M Sep/2025
Essilor EUR 2.79B 535M Jun/2025
Fresenius EUR 1.23B 1.16B Jun/2025
Fresenius Medical Care EUR 1.26B 459.13M Sep/2025
Getinge SEK 2.96B 720M Dec/2024
Givaudan CHF 603M 3M Jun/2024
GlaxoSmithKline GBP 3.3B 303M Sep/2025
GN Store Nord DKK 767M 363M Sep/2025
GRIFOLS EUR 558.69M 194.13M Jun/2025
Hikma Pharmaceutical USD 236M 48M Jun/2025
Lonza CHF 1.11B 286M Dec/2024
Merck EUR 1.17B 161M Jun/2025
Novartis USD 9.56B 2.9B Sep/2025
Philips EUR 1.91B 90M Sep/2025
Roche Holding CHF 7.55B 579M Jun/2025
RWE EUR 3.05B 292M Sep/2025
Sanofi EUR 7.66B 1.25B Dec/2025